Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
MediciNova logo — Focused on innovative small-molecule therapeutics, addressin...

MediciNova

Focused on innovative small-molecule therapeutics, addressing unmet medical needs with strategic alliances and a diversified clinical portfolio.

Founded 2000 Post Ipo Equity Total: $136.00M Biotechnology, Health and Wellness +1

General Information

Company Name MediciNova
Founded Year 2000
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when MediciNova moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MediciNova

MediciNova is a biopharmaceutical company established in 2000 with a focus on innovative small-molecule therapeutics. The company is committed to addressing unmet medical needs, primarily in the U.S. market, through a diversified clinical portfolio and strategic alliances with Japanese pharmaceutical firms. Their pipeline includes clinical-stage compounds targeting acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, interstitial cystitis, and solid tumor cancers. Their $20.00M Post-IPO Equity investment on 12 January 2021 was secured from 3D Investment Partners. MediciNova's emphasis on appealing commercial potential and robust patent claims makes it a compelling prospect for investors in the Biotechnology, Health and Wellness, and Pharmaceutical industries.

Taxonomy: biopharmaceutical, small-molecule therapeutics, clinical portfolio, unmet medical needs, strategic alliances, Japanese pharmaceutical firms, innovative treatments, drug development, patent assets, acute exacerbations, multiple sclerosis, addiction treatment, neuropathic pain, interstitial cystitis, solid tumor cancers

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 1
Investor
12 Jan 2021
Post-IPO Equity •••••• - 13 Feb 2018
Post-IPO Equity •••••• 1
Investor
20 Aug 2012
Post-IPO Equity •••••• - 30 Jan 2007
Venture Round •••••• 7
Investor Investor Investor Investor
•••• •••• 		01 Aug 2004

MediciNova Alternatives & Competitors

MediciNova vs
Tueo Health
Tueo Health

The name Tueo is derived from a Latin word meaning to observe, care for, and maintain. Tueo Health i...

Convertible Note
Health Care, Health and Wellness
MediciNova vs
Ark Clinical Research
Ark Clinical Research United States

Better Research for a Better Life

29 employees
Health Care
MediciNova vs
American Academy of Allergy, Asthma and Immunology - AAAAI
American Academy of Allergy, Asthma and Immunology - AAAAI United States

The American Academy of Allergy, Asthma & Immunology is the largest professional medical organizatio...

128 employees
Health Care

FAQ About MediciNova

Focused on innovative small-molecule therapeutics, addressing unmet medical needs with strategic alliances and a diversified clinical portfolio.
MediciNova was founded in 2000.
MediciNova operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.
MediciNova has completed 5 funding rounds, raising a total of $136.00M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to MediciNova include Tueo Health, Ark Clinical Research, American Academy of Allergy, Asthma and Immunology - AAAAI, RESPIRATORY CLINICAL TRIALS LIMITED, IMIC Medical Research, a Rovia Clinical Research Company. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MediciNova and Tueo Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MediciNova and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy